Chengdu Easton Biopharmaceuticals Co Ltd (688513) — Financial Flexibility Index
Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Financial Flexibility Index of 0.12x as of September 2025. Free cash flow of CN¥85.65 Million (operating CF CN¥61.35 Million minus capex CN¥24.30 Million) represents 0% of total liabilities (CN¥692.94 Million). Check Chengdu Easton Biopharmaceuticals Co Ltd (688513) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chengdu Easton Biopharmaceuticals Co Ltd Financial Flexibility Index (2013–2024)
Historical Financial Flexibility Index trend for Chengdu Easton Biopharmaceuticals Co Ltd across 12 annual periods. See working capital to net assets of Chengdu Easton Biopharmaceuticals Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Chengdu Easton Biopharmaceuticals Co Ltd (2013–2024)
Year-by-year free cash flow to debt coverage for Chengdu Easton Biopharmaceuticals Co Ltd. For the full company profile including market capitalisation, see 688513 market cap overview.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.54x | CN¥380.66 Million | CN¥263.24 Million | CN¥702.21 Million | ▼ -10.6% |
| 2023 | 0.61x | CN¥450.51 Million | CN¥275.25 Million | CN¥743.33 Million | ▼ -29.3% |
| 2022 | 0.86x | CN¥491.27 Million | CN¥151.94 Million | CN¥573.08 Million | ▲ +2.6% |
| 2021 | 0.84x | CN¥403.89 Million | CN¥147.60 Million | CN¥483.60 Million | ▲ +2.4% |
| 2020 | 0.82x | CN¥355.33 Million | CN¥156.52 Million | CN¥435.61 Million | ▼ -0.4% |
| 2019 | 0.82x | CN¥237.24 Million | CN¥141.83 Million | CN¥289.64 Million | ▼ -30.2% |
| 2018 | 1.17x | CN¥243.42 Million | CN¥166.79 Million | CN¥207.50 Million | ▲ +58.3% |
| 2017 | 0.74x | CN¥108.72 Million | CN¥85.70 Million | CN¥146.70 Million | ▼ -22.0% |
| 2016 | 0.95x | CN¥123.88 Million | CN¥106.06 Million | CN¥130.43 Million | ▼ -52.0% |
| 2015 | 1.98x | CN¥86.00 Million | CN¥50.57 Million | CN¥43.42 Million | ▲ +130.1% |
| 2014 | 0.86x | CN¥68.75 Million | CN¥46.71 Million | CN¥79.85 Million | ▼ -28.8% |
| 2013 | 1.21x | CN¥104.23 Million | CN¥28.12 Million | CN¥86.24 Million | — |